Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$75.00
Provider: GlobalData
$50.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BioPorto A/S Updates on Expected Rights Issue


Wednesday, 26 Jun 2013 08:12am EDT 

BioPorto A/S announced that the Company's Board of Directors expects to make a final decision on the issue and to publish the prospectus in mid-August 2013. The issue is estimated to include up to 70.7 million shares of nominal value DKK 1.00 at a subscription price of DKK 1.00. The shareholders will thus have pre-emptive rights to new shares in the ratio 2:3 (equivalent to 2 existing shares entitling the holder to subscribe for 3 new shares). The Board expects to set a minimum for the issue of DKK 40 million meaning that the Company could raise gross proceeds of between DKK 40 million and DKK 70.7 million if the issue is implemented. 

Company Quote

1.7
0.04 +2.41%
10:59am EST